Genomic profiling of patients with metastatic castration-resistant prostate cancer (mCRPC) for the evaluation of rucaparib: Next-generation sequencing (NGS) of tumour tissue and cell-free DNA (cfDNA)
European Urology Supplements(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络